People
Anthony Philippakis
General Partner at GV
Cambridge, Massachusetts
Signal profile
Anthony Philippakis
VCInvestor
Venture Partner at GV
gv.com/team/anthony-philippak...Cambridge, Massachusetts
- Current affiliation
- GV ยท General Partner
- Investment range
- $250K โ $50M
- Sweet spot
- $25M
- Investments on record
- 24
Investments
| $11M2026-04 | Beacon Biosignals | Anthony Philippakis, Hemant Taneja, JSL Health, Palo Santo VC, Daniel Goldberg, Kicker Ventures, Samsung Next, GV |
| $77M2026-04 | Iterative Health | Anthony Philippakis |
| $20M2026-01 | Prudentia Sciences, Inc. | Anthony Philippakis |
| $97M2025-11-13 | Beacon Biosignals | Anthony Philippakis, Hemant Taneja, GV, Innoviva, Nexus NeuroTech Ventures, Catalio Capital Management, Takeda, General Catalyst, Caitlin Donovan, Logos Capital, Casdin Capital, Indicator Ventures, Alumni Ventures, Synetro Group, Iaso Ventures |
| $30M2025-03 | Layer Health | Anthony Philippakis |
| $7M2025-01 | Prudentia Sciences, Inc. | Anthony Philippakis |
| $100M2024-11 | Trace Neuroscience | Anthony Philippakis |
| $260M2024-07 | Cardurion Pharmaceuticals | Anthony Philippakis |
| $57M2024-01 | Moonwalk Biosciences | Robert Nelsen, Anthony Philippakis |
| $4M2023-11 | Layer Health | Anthony Philippakis |
| $150M2023-06 | Bitterroot Bio | Anthony Philippakis, Steven Gillis |
| $35M2023-06 | Delve Bio | Anthony Philippakis |
| $60M2021-08 | Genome Medical | Anthony Philippakis |
| $110M2021-03 | Tenaya Therapeutics | Anthony Philippakis |
| $94M2021-01 | Verve Therapeutics | Anthony Philippakis |
| $82M2020-11 | Decibel Therapeutics | Anthony Philippakis |
| $63M2020-06 | Verve Therapeutics | Anthony Philippakis |
| $โ2020-01 | EveryONE Medicines | Anthony Philippakis |
| $92M2019-10 | Tenaya Therapeutics | Anthony Philippakis |
| $59M2019-05 | Verve Therapeutics | Anthony Philippakis |
| $190M2019-02 | Maze Therapeutics | Anthony Philippakis |
| $55M2018-06 | Decibel Therapeutics | Anthony Philippakis |
| $93M2017-09 | Gritstone bio | Anthony Philippakis |
| $โ2017-07 | Decibel Therapeutics | Anthony Philippakis |